Paromomycin
Back to searchMolecule Structure
Scientific Name
Paromomycin
Description of the Drug
Paromomycin is an aminoglycoside antibiotic used in the treatment of acute and chronic intestinal amebiasis, and as an adjunct for the management of hepatic coma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01421
http://www.drugbank.ca/drugs/DB01421
Brand Name(s)
Not Available
Company Owner(s)
Parke Davis Div Warner Lambert Co, Sun Pharmaceutical Industries Inc, Parkedale Pharmaceuticals Inc, King Pharmaceuticals Inc Sub Pfizer Inc, Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4072 | |
PharmGKB | PA164784023 | |
Human Metabolome Database | HMDB0015490 | |
DrugBank | DB01421 | |
PubChem: Thomson Pharma | 24380735 | |
PubChem | 165580 | |
Mcule | MCULE-1528618434 | |
NMRShiftDB | 70114032 | |
Nikkaji | J8.952D | |
PDBe | PAR | |
BindingDB | 50240054 | |
EPA CompTox Dashboard | DTXSID8023424 | |
DrugCentral | 2067 | |
Brenda | 210630 | 2215 |
ChemicalBook | CB6911922 | |
rxnorm | PAROMOMYCIN | PAROMOMYCIN SULFATE |
KEGG Ligand | C00832 | |
ChEBI | 7934 | |
ZINC | ZINC000060183170 |